Immune System Diseases

AstraZeneca Signs $110M AI-Driven R&D Deal with CSPC Pharmaceutical for Chronic Disease Drugs

1 month ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, AstraZeneca, China pharma, Chronic disease, Collaboration, Dosage Forms, Drug Discovery, Drug Industry, GZMH gene, Immune System Diseases, milestone payments, oral therapies

AstraZeneca; CSPC Pharmaceutical; AI drug discovery; chronic diseases; immunological diseases; oral therapies; R&D collaboration; China pharma; milestone payments; pharmaceutical industry

UK Regulator Approves Pharming’s Joenja for Rare Immune Disorder APDS, Leveraging FDA Review

10 months ago talkbio0Tagged APDS, Approved, Immune System Diseases, Infrequent, Joenja, leniolisib, Medicines And Healthcare Products Regulatory Agency, Molecular Farming, pamidronate, Review [Publication Type], United States Food and Drug Administration

Joenja, leniolisib, APDS, MHRA approval, FDA review, rare immune disorder, Pharming

Third Arc Bio Debuts with $165M Funding and Former J&J Executives at the Helm

1 year ago talkbio0Tagged AIDS related complex, Immune System Diseases, J&J, Third

Third Arc Bio, J&J, biotech, funding, executives, cancer, immune disease